Obstetric Hemorrhage for the Intensivist: Stopping the Major Cause of Global Maternal Mortality

Concurrent Session Moderator(s)

• MB

  Marie Baldisseri, MD, MPH, FCCM

  Professor of Critical Care Medicine and Neurocritical Care
  University of Pittsburgh Medical Center
  Pittsburgh, Pennsylvania

  No relevant financial relationship(s) to disclose

Physiologic changes in blood volume and hemostasis that accompany pregnancy mitigate the risk of maternal hemorrhage; however, these adaptive mechanisms can be overcome in superimposed pathophysiologic states. Uterotonic and hemostatic adjuncts constitute the first line of defense in combatting postpartum hemorrhage. Familiarity with these agents' indications, contraindications, and pharmacokinetics is crucial for successful management of hemorrhage in the ICU. Early recognition and management are crucial because failure to treat potential contributors to hemorrhage can lead to adverse outcomes.

Presentations:

• Physiology and Pathophysiology of Maternal Hemorrhage: From Hemostasis in Pregnancy to Abnormal Placentation
  

  Concurrent Session Faculty: Scott A. Harvey, MD, MS, FACOG – University of California San Diego
• Pharmacologic Adjuncts in Obstetric Hemorrhage: First Line and Beyond
  

  Concurrent Session Faculty: Mary J. Reed, MD, FCCM – Geisinger Medical Center
• Obstetric Hemorrhage for the Intensivist: Stopping the Major Cause of Global Maternal Mortality
  

  Concurrent Session Faculty: Sujanthy S. Rajaram, MD, MPH, FCCP – n/a